Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

BUY
$47.98 - $54.4 $3,886 - $4,406
81 Added 9.35%
947 $51,000
Q4 2023

Jan 26, 2024

BUY
$48.48 - $57.85 $41,983 - $50,098
866 New
866 $44,000
Q2 2023

Jul 19, 2023

SELL
$63.71 - $70.74 $5,096 - $5,659
-80 Reduced 7.05%
1,054 $67,000
Q1 2023

May 03, 2023

BUY
$65.71 - $74.53 $197 - $223
3 Added 0.27%
1,134 $78,000
Q4 2022

Jan 25, 2023

BUY
$68.48 - $81.09 $9,655 - $11,433
141 Added 14.24%
1,131 $81,000
Q3 2022

Nov 02, 2022

BUY
$0.13 - $76.84 $128 - $76,071
990 New
990 $70,000
Q3 2021

Nov 24, 2021

SELL
$59.17 - $69.31 $70,648 - $82,756
-1,194 Closed
0 $0
Q2 2021

Jul 28, 2021

BUY
$61.91 - $67.42 $619 - $674
10 Added 0.84%
1,194 $80,000
Q1 2021

May 05, 2021

SELL
$59.34 - $66.74 $28,957 - $32,569
-488 Reduced 29.19%
1,184 $75,000
Q4 2020

Feb 09, 2021

SELL
$57.74 - $65.43 $37,357 - $42,333
-647 Reduced 27.9%
1,672 $104,000
Q3 2020

Oct 27, 2020

BUY
$57.43 - $63.64 $5,685 - $6,300
99 Added 4.46%
2,319 $140,000
Q2 2020

Jul 16, 2020

BUY
$54.82 - $64.09 $80,804 - $94,468
1,474 Added 197.59%
2,220 $131,000
Q1 2020

May 20, 2020

SELL
$46.4 - $67.43 $136,740 - $198,716
-2,947 Reduced 79.8%
746 $42,000
Q4 2019

Jan 27, 2020

SELL
$49.21 - $64.19 $75,832 - $98,916
-1,541 Reduced 29.44%
3,693 $237,000
Q3 2019

Oct 15, 2019

BUY
$42.77 - $50.71 $187,503 - $222,312
4,384 Added 515.76%
5,234 $266,000
Q2 2019

Jul 18, 2019

BUY
$44.62 - $49.34 $2,766 - $3,059
62 Added 7.87%
850 $39,000
Q1 2019

Apr 22, 2019

SELL
$45.12 - $53.8 $3,338 - $3,981
-74 Reduced 8.58%
788 $38,000
Q4 2018

Feb 14, 2019

BUY
$48.76 - $63.23 $42,031 - $54,504
862 New
862 $45,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Bay Harbor Wealth Management, LLC Portfolio

Follow Bay Harbor Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bay Harbor Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bay Harbor Wealth Management, LLC with notifications on news.